Cellular Dynamics' Q2 Revenues More Than Double | GenomeWeb

NEW YORK (GenomeWeb News) – Cellular Dynamics International today reported that its second quarter revenues increased 123 percent year over year, driven by sales of its iCell products.

The Madison, Wis.-based firm brought in total revenues of $2.8 million for the three months ended June 30, compared to $1.3 million for the second quarter of 2012. It said that the revenue growth was primarily attributable to growth in unit sales of its iCell human induced pluripotent stem cell-derived products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.